Results for trial translation from German to Norwegian

Human contributions

From professional translators, enterprises, web pages and freely available translation repositories.

Add a translation

German

Norwegian

Info

German

trial

Norwegian

rettssaken

Last Update: 2021-08-04
Usage Frequency: 1
Quality:

Reference: Anonymous

German

trial period:

Norwegian

prøveperiode:

Last Update: 2009-12-05
Usage Frequency: 1
Quality:

Reference: Anonymous

German

the database can not be loaded. trial period is expired.

Norwegian

databasen kan ikke innleses. prøveperioden er utgått.

Last Update: 2009-12-05
Usage Frequency: 1
Quality:

Reference: Anonymous

German

\m/ vikings \m/ episode 4 ~ "trial" ~

Norwegian

brow

Last Update: 2016-10-27
Usage Frequency: 1
Quality:

Reference: Anonymous
Warning: Contains invisible HTML formatting

German

(european drug abuse prevention trial – www.eudap.net) zeitigte viel versprechende ergebnisse.

Norwegian

likevel blir det nye begrepet ”forebyggende folkehelsearbeid” stadig oftere nevnt av en del medlemsstater (italia, nederland, slovakia) og norge.

Last Update: 2014-02-06
Usage Frequency: 1
Quality:

Reference: Anonymous

German

die wirksamkeit von rotateq wurde in einer placebokontrollierten studie (rotavirus efficacy and safety trial [rest]) auf zwei arten untersucht:

Norwegian

beskyttelseseffekten ved rotateq ble evaluert på to måter i den placebokontrollerte studien ”rotavirus efficacy and safety trial” (rest):

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Reference: Anonymous

German

adopt („a diabetes outcome progression trial“) war eine multizentrische, doppel-blinde, kontrollierte studie mit einer behandlungsdauer von 4 bis 6 jahren (mittlere behandlungsdauer 4 jahre), in der bei 4.351 medikamentös nicht-vorbehandelten patienten mit kürzlich (≤ 3 jahre) diagnostiziertem typ-2-diabetes rosiglitazon in einer dosierung von 4 bis 8 mg/tag mit metformin (500 mg bis 2.000 mg/tag) und glibenclamid (2,5 bis 15 mg/tag) verglichen wurde.

Norwegian

adopt (a diabetes outcome progression trial) var en multisenter, dobbelt-blindet, kontrollert studie med en behandlingsvarighet på 4-6 år (median varighet på 4 år), hvor rosiglitazon med doser fra 4-8 mg/dag ble sammenlignet med metformin (500 mg til 2000 mg/dag) og glibenklamid (2,5 mg til 15 mg/dag) i 4351 tidligere ubehandlede personer som nylig var diagnostisert (≤3 år) med type 2 diabetes.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Reference: Anonymous

Get a better translation with
7,746,049,564 human contributions

Users are now asking for help:



We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. Learn more. OK